Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, vaccines and immunoinformatics approaches, and Immunotherapy and Immune Responses.
Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues
Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
Targets of influenza human T-cell response are mostly conserved in H5N1
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice
Profiling the SARS-CoV-2-specific T-cell response
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Durability of immune responses to mRNA booster vaccination against COVID-19
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination
Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Humoral and cellular immune memory to four COVID-19 vaccines
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
Defining the risk of SARS-CoV-2 variants on immune protection
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans
Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern